Conavi Medical announces closing of financing to bolster novel intravascular imaging technology

Conavi Medical, a leader in hybrid intravascular imaging, recently announced closing $12.5 million USD of funding, including participation from existing investors. The funding is part of a larger effort by Conavi Medical to raise up to $30 million USD to expand its commercial footprint and ready the system for broad market adoption.

Conavi is an OBIO® member, an alumnus of our CAAP® and workforce development programs and presented at the OBIO® Investment Summit.

Previous
Previous

FluidAI Medical announces $15M in Series A funding for AI-driven postoperative monitor at HLTH 2023

Next
Next

Allarta receives award from JDRF to advance its work in creating a functional cure for type 1 diabetes